Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

Delayed Quote. Delayed  - 02/12 03:59:56 pm
12.01 USD   +0.67%
02/05 SUCAMPO PHARMAC : Announces Webcast of Its Presentation at the 2016 ..
02/04 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at ..
01/12 SUCAMPO PHARMAC : Enters Into Exclusive Option and Collaboration Agr..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
11.25(c) 11.45(c) 11.67(c) 11.93(c) 12.0006(c) Last
562 473 448 636 292 937 388 310 474 153 Volume
-2.43% +1.78% +1.92% +2.23% +0.59% Change
More quotes
Financials ($)
Sales 2015 141 M
EBIT 2015 51,2 M
Net income 2015 28,3 M
Debt 2015 233 M
Yield 2015 -
Sales 2016 202 M
EBIT 2016 97,3 M
Net income 2016 48,8 M
Debt 2016 199 M
Yield 2016 -
P/E ratio 2015 19,58
P/E ratio 2016 11,62
EV / Sales 2015 5,53x
EV / Sales 2016 3,68x
Capitalization 544 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
02/11 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
02/05 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2016 Leer..
02/04 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Lee..
01/14 SUCAMPO PHARMACEUTICALS : Entry into a Material Definitive Agreement, Regulation..
01/12 SUCAMPO PHARMACEUTICALS : Enters Into Exclusive Option and Collaboration Agreeme..
01/11 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
01/11 Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer ..
01/08 SUCAMPO PHARMACEUTICALS : Provides Update to 2015 and Confirms 2016 Financial Gu..
More news
Sector news : Bio Therapeutic Drugs
02/13 LONZA : Pease Lonza may add up to 400 jobs Firm requests city cut building permi..
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12 AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on SUCAMPO PHARMACEUTICALS, I 
2015The bullish trend is not over
More Strategies
News from SeekingAlpha
02/08 Cancer Prevention Pharmaceuticals on deck for IPO
01/15 Healthcare ratings roundup
01/07 Synergy Pharmaceuticals Looks More Interesting Today
01/07 Sucampo sees non-GAAP EPS of $0.65 - 0.75 for 2015
2015 Soligenix's candidate for oral mucositis shows encouraging results in mid-sta..


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions